Fiduciary Alliance’s MiMedx Group MDXG Stock Holding History

Fiduciary Alliance’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.9K	Sell	14,250 -1,600	-10%	-$5.84K	﹤0.01%	534
2026 Q1	$61.5K	Hold	15,850	–	–	﹤0.01%	544
2025 Q4	$107K	Hold	15,850	–	–	0.01%	498
2025 Q3	$111K	Sell	15,850 -800	-5%	-$5.56K	0.01%	487
2025 Q2	$102K	Hold	16,650	–	–	0.01%	474
2025 Q1	$127K	Hold	16,650	–	–	0.01%	376
2024 Q4	$160K	Buy	+16,650	New	+$130K	0.02%	342
2023 Q3	–	Sell	-200	Closed	-$1.32K	–	628
2023 Q2	$1.32K	Buy	+200	New	+$1.02K	﹤0.01%	836
2023 Q1	–	Sell	-200	Closed	-$556	–	561
2022 Q4	$556	Buy	+200	New	+$598	﹤0.01%	841

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fiduciary Alliance's MDXG Position: Q2 2026 in Review

Fiduciary Alliance reduced its MiMedx Group (MDXG) stake by 10% in Q2 2026, selling an estimated $5.84K and leaving 14,250 shares worth $54.9K. The position accounts for ﹤0.01% of the portfolio, ranked #534.

Fiduciary Alliance first reported a position in MDXG in Q4 2022 and has held it in 9 quarters since. The position peaked at $160K in Q4 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Fiduciary Alliance held 14,250 shares of MiMedx Group worth $54.9K as of Q2 2026.
Fiduciary Alliance sold 1,600 MiMedx Group shares in Q2 2026, an estimated $5.84K.
MiMedx Group made up ﹤0.01% of Fiduciary Alliance's portfolio in Q2 2026, its #534 holding.
Fiduciary Alliance first reported a position in MiMedx Group in Q4 2022 and has held it in 9 quarters since.
Fiduciary Alliance's MiMedx Group position peaked at $160K in Q4 2024.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.